Backstory: The Road to PSMA-Targeting Radionuclides
This new form of treatment for metastatic prostate cancer is being used in Europe, Australia and elsewhere, and being tested in clinical trials in the U.S. As part of my series on PSMA-targeting, here’s more of the story: Neil Bander, M.D., Director of Urological Oncology Research at Weill Cornell and a pioneer in the study […]